Christopher Carroll

Christopher Carroll has a diverse work experience in the field of biosciences. Christopher is currently serving as an Associate Director at Neomorph, Inc. since March 2021. Prior to that, they worked as an Associate Director of Discovery Biology at Design Therapeutics from September 2020 to March 2021. From December 2019 to September 2020, they held the position of Principal Scientist at Bristol-Myers Squibb. Christopher also worked at Celgene, first as a Senior Scientist from July 2017 to December 2019, and later as a Principal Scientist from October to December 2019. Before joining the industry, they gained academic experience as an Assistant Professor at Yale University from January 2012 to June 2017. Christopher started their career as a Postdoctoral Fellow at Stanford University School of Medicine from May 2005 to December 2011.

Christopher Carroll pursued their education in the field of biology, focusing on biochemistry and molecular biology. Christopher obtained their Bachelor of Science (BS) degree in Cell/Cellular and Molecular Biology from the University of California Santa Cruz between 1994 and 1998. Christopher furthered their education by earning a Doctor of Philosophy (PhD) degree in Biochemistry and Molecular Biology from the University of California, San Francisco, commencing in 1998 and completing it in 2005.